McKesson (MCK) closed at $488.78 in the latest trading session, marking a -1.95% move from the prior day. This change lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw an upswing of ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Robert W. Baird analyst Eric Coldwell downgraded the rating on McKesson (MCK – Research Report) to a Hold today, setting a price target ...

Deutsche Bank analyst George Hill maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $579.00.

Today, Benzinga's options scanner identified 12 options transactions for McKesson. This is an unusual occurrence. The ...

We recently compiled a list of 10 Best Stocks To Buy Right Now According To Billionaire Cliff Asness. In this article, we ...

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The Zacks Medical - Dental Supplies industry, to which McKesson belongs, has gained 0.9% over this period. Now the key question is: Where could the stock be headed in the near term? While media ...

McKesson (NYSE:MCK) shares fell sharply on Thursday after the medical distributor set its Q2 outlook for fiscal 2025 below expectations. Presenting at the Wells Fargo Healthcare Conference ...

McKesson declined about 20% in the last few weeks and sentiment suddenly turned. Of course, McKesson is performing hand-in-hand with the overall market and we can expect that McKesson will ...

Shares of McKesson (MCK) fell sharply on Thursday ... Meanwhile, Zimmer Biomet (ZBH) shares sank after the medical products company warned that issues with an enterprise resource system would ...